BackgroundThe efficacy of psychopharmacological treatments has been called into question.
Psychiatrists are unfamiliar with the effectiveness of common medical drugs.AimsTo put …

Background Because of the high number of people with schizophrenia not responding
adequately to monotherapy with antipsychotic agents, the evidence regarding the efficacy and …

… Markus Dold … This is calculated using the mean number of participants per cluster (m)
and the intraclass correlation coefficient (ICC) (design effect = 1+(m‐1)*ICC) (Donner 2002) …

Importance There is debate about the effectiveness of psychiatric treatments and whether
pharmacotherapy or psychotherapy should be primarily used. Objectives To perform a …

… that clozapine was the most efficacious antipsychotic in a network meta-analysis (NMA) of
trials for treatment of nonrefractory schizophrenia, but the superiority was again driven by old …

Because of the high number of patients with obsessive–compulsive disorder (OCD) not
responding satisfactorily to initial monotherapy with serotonin reuptake inhibitors (SRIs), the …

… In conclusion, based on the current evidence clozapine remains the gold standard and
mainstay in the pharmacological treatment of refractory schizophrenia. However, due to its risk …

Background Many people with schizophrenia do not achieve a satisfactory treatment
response with just antipsychotic drug treatment and various adjunct medications are used to …

We establish the existence of the top quark using a 67 pb− 1 data sample of pp collisions at
s= 1.8 TeV collected with the Collider Detector at Fermilab (CDF). Employing techniques …

… Dr Dold has received a travel grant from Janssen-Cilag. Dr Kasper has received grant/research
support from Bristol Myers-Squibb, Eli Lilly, GlaxoSmithKline, Lundbeck, Organon, Pfizer, …